Literature DB >> 17428662

Structure-based organic synthesis of unnatural aeruginosin hybrids as potent inhibitors of thrombin.

Stephen Hanessian1, Karolina Ersmark, Xiaotian Wang, Juan R Del Valle, Niklas Blomberg, Yafeng Xue, Ola Fjellström.   

Abstract

Based on X-ray crystallographic data of complexes of chlorodysinosin A with the enzyme thrombin, a series of analogs were synthesized varying the nature of the P(1), P(2), and P(3) pharmacophoric sites and the central octahydroindole carboxyamide core. In general, introduction of a hydrophobic substituent on the d-leucine amide residue dramatically improved the inhibition of the enzyme. This is rationalized based on a better fit of the P(3) subunit in the hydrophobic S(3) enzyme site. Single digit nanomolar inhibition expressed as IC(50) was observed for several analogs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428662     DOI: 10.1016/j.bmcl.2007.03.075

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery.

Authors:  George E Chlipala; Shunyan Mo; Jimmy Orjala
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

2.  Synthesis of hydroxylated bicyclic amino acids from L-tyrosine: octahydro-1H-indole carboxylates.

Authors:  Joshua G Pierce; Dhanalakshmi Kasi; Makoto Fushimi; Anthony Cuzzupe; Peter Wipf
Journal:  J Org Chem       Date:  2008-09-04       Impact factor: 4.354

3.  Total synthesis of aeruginosin 98B.

Authors:  Barry M Trost; Toshiyuki Kaneko; Neil G Andersen; Christoph Tappertzhofen; Bruce Fahr
Journal:  J Am Chem Soc       Date:  2012-11-12       Impact factor: 15.419

4.  Identification of berberine as a direct thrombin inhibitor from traditional Chinese medicine through structural, functional and binding studies.

Authors:  Xing Wang; Yuxin Zhang; Ying Yang; Xia Wu; Hantian Fan; Yanjiang Qiao
Journal:  Sci Rep       Date:  2017-03-09       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.